Krishnan, Chandramouli
Adeeko, Olugbenga P.
Washabaugh, Edward Peter
Augenstein, Thomas E
Brudzinski, Maureen
Portelli, Alyssa
Kalpakjian, Claire Zabelle
Funding for this research was provided by:
National Institutes of Health (R41-HD111289)
Article History
Received: 23 January 2024
Accepted: 10 April 2024
First Online: 24 April 2024
Declarations
:
: All participants in the design sprints provided verbal consent to participation and the study was determined to be exempt from ongoing Institutional Review Board oversight by the University of Michigan IRBMED. The participant for the biomechanical simulation provided written consent to participation using a form approved by the Wayne State University Institutional Review Board.
: Not applicable.
: OPA is the inventor of the original NewGait device and CEO/Founder of the company that developed and sells the product. No other conflicts exist.